Fate of nanomedicines after intravenous administration
Fate of nanoparticles used as drugs in the body
Article REF: MED5050 V1
Fate of nanomedicines after intravenous administration
Fate of nanoparticles used as drugs in the body

Author : Frédéric LAGARCE

Publication date: October 10, 2014 | Lire en français

Logo Techniques de l'Ingenieur You do not have access to this resource.
Request your free trial access! Free trial

Already subscribed?

2. Fate of nanomedicines after intravenous administration

2.1 Pharmacokinetics of nanoparticles

After blood administration, nanoparticles circulate in the circulatory torrent. To reach the tissues, these carriers will have to pass through arteries and then smaller-diameter arterioles. Thus, a dose of nanoparticles administered into a vein will reach the heart via the vena cava, then necessarily pass through the lungs to return to the heart via the pulmonary vein and rejoin the arterial circulation via the aorta (figure 2 ). Passage through the lungs is not a problem for small...

You do not have access to this resource.
Logo Techniques de l'Ingenieur

Exclusive to subscribers. 97% yet to be discovered!

You do not have access to this resource. Click here to request your free trial access!

Already subscribed?


Ongoing reading
Fate of nanomedicines after intravenous administration

Article included in this offer

"Nanosciences and nanotechnologies"

( 135 articles )

Complete knowledge base

Updated and enriched with articles validated by our scientific committees

Services

A set of exclusive tools to complement the resources

View offer details